Cutaneous adverse reaction (includes severe cutaneous adverse drug reaction (SCAR))

• (2026): Kwack DW+, J Clin Neurol 22(1), 122-124 (association) (pharmacogenomics)
• (2025): Ahmed AF+, Heliyon 11(1), e41108 (pharmacogenomics)
• (2025): Alvarado AT+, Front Pharmacol Aug (e-Collection) [REVIEW] (pharmacogenomics)
• (2024): Abtahi-Naeini B+, Iran J Allergy Asthma Immunol 23(2), 139-148 (259 cases)
• (2022): Mushiroda T, J Hum Genet May, Online ahead of print [REVIEW]
• (2021): Ahmed AF+, J Pers Med 11(5), 383
• (2021): Villanueva-Paz M+, J Clin Med 10(22), 5317 [REVIEW]
• (2019): Kim EY+, Transl Clin Pharmacol 27(2), 64 (severe / 5 cases)

DRESS syndrome (Drug-induced hypersensitivity syndrome / DIHS)

• (2023): Alotaibi M, Cureus 15(3), e35701 [REVIEW]
• (2013): Kardaun SH+, Br J Dermatol 169(5), 107135%

Rash

• (2019): Baftiu A+, Eur J Clin Pharmacol Apr, Epub ahead of print [REVIEW]

Stevens-Johnson syndrome and toxic epidermal necrolysis (SJS/TEN)

• (2011): Ferrandiz-Pulido C+, Med Clin (Barc) 136(13), 583 [REVIEW]

Toxic epidermal necrolysis (Lyell's syndrome)

• (2011): Ferrandiz-Pulido C+, Med Clin (Barc) 136(13), 583

Delusions

• (2023): Balcerac A+, Psychiatry Res Jul, Online ahead of print

Fever (pyrexia) (includes hyperpyrexia)

• (2019): Baftiu A+, Eur J Clin Pharmacol Apr, Epub ahead of print [REVIEW]

Psychiatric adverse effect

• (2025): Sun W+, Front Pharmacol Jan (e-Collection) [REVIEW] (pharmacovigilance / pharmacoepidemiology)

Serotonin syndrome

• (2015): Zadori D+, Expert Opin Drug Saf 14(6), 877 [REVIEW]

Suicidal ideation

• (2022): Koseki T+, Front Psychiatry Jan (e-Collection) (association)

Tic disorder

• (2020): Peters J+, J Neurol Aug, Online ahead of print [REVIEW]

Hepatotoxicity / liver injury / acute liver injury / drug-induced liver injury (DILI)

• (2025): Petrović S+, Int J Clin Pharm Jun, Online ahead of print (pharmacovigilance / pharmacoepidemiology)
• (2021): Villanueva-Paz M+, J Clin Med 10(22), 5317 [REVIEW]

Enuresis (urinary incontinence)

Coagulopathy / coagulation dysfunction / clotting factor deficiency (includes disseminated intravascular coagulation / DIC)

• (2025): Mansoor A+, Drugs Real World Outcomes Mar (e-Collection) [REVIEW]

Bone loss / bone disorder

• (2026): Gou C+, Naunyn Schmiedebergs Arch Pharmacol Feb, Online ahead of print (pharmacovigilance / pharmacoepidemiology)

Osteoporosis

• (2013): Zofkova I, Vnitr Lek (Czech) 59(1), 59 [REVIEW]

Rhabdomyolysis

• (2021): Siniscalchi A+, Psychopharmacol Bull 51(4), 105-116 [REVIEW]

Cataract

• (2013): Lei JY+, Zhonghua Yan Ke Za Zhi (Chinese) 49(5), 468 [REVIEW]

Nystagmus

• (2015): Abdel-Rahman O+, Future Oncol Nov, Epub ahead of print [REVIEW]
• (2015): Wu D+, Epilepsy Behav Case Rep 4, 74

Ocular adverse effect

• (2019): Hamed SA, Expert Rev Clin Pharmacol March, Epub ahead of print [REVIEW]

Adverse effects / adverse reactions

• (2026): Ogura T+, Cureus 18(3), e105027 [REVIEW] (pharmacovigilance / pharmacoepidemiology)
• (2025): Alvarado AT+, Pharmaceuticals (Basel) 18(12), 1872 (pharmacogenomics)

Cross-sensitivity reactions

• (2019): Baftiu A+, Eur J Clin Pharmacol Apr, Epub ahead of print [REVIEW]